MYGN Operating Cash Flow (Statement)

Myriad Genetics Inc · Operating Cash Flow (Statement)

MYGN logo

MYGN Operating Cash Flow (Statement)

Latest reported-$8.30M
MYGN Quarterly Cash from Operations ($2.70M → -$8.30M)
High-resolution chart · PNG

MYGN operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-8,300,000
-15,700,000
10,600,000
21,100,000
-13,600,000
-16,300,000
6,600,000
700,000
2,600,000
-18,600,000
-54,700,000
-22,100,000
-900,000
-33,200,000
-7,700,000
-2,800,000
-49,700,000
-46,500,000
-9,900,000
-39,300,000
-4,400,000
71,800,000
-14,400,000
-59,300,000
30,000,000
16,800,000
-1,900,000
15,800,000
31,500,000
6,600,000
37,800,000
7,800,000
47,900,000
11,500,000
33,000,000
23,500,000
36,600,000
41,100,000
31,400,000
-2,900,000
56,400,000
45,900,000
52,100,000
29,800,000
51,044,000
29,900,000
52,600,000
7,000,000
40,933,000
11,249,000
47,549,000
90,482,000
63,000,000
37,396,000
22,114,000
51,356,000
41,740,000
40,747,000
27,530,000
31,824,000
36,302,000
28,036,000
37,125,000
29,296,000
46,522,000
42,656,000
42,727,000
23,181,000
38,929,000
7,869,000
41,643,000
-4,399,000
111,840,000
4,444,000
150,000
-12,698,000
254,000
-4,921,000
-6,883,000
-14,301,000
-3,288,000
-6,889,000
-6,900,000
-10,950,000
1,501,000
-8,688,000
-4,343,000
-11,774,000
-6,485,000
-3,996,000
-6,724,000
-13,675,000
-1,433,000
-17,736,000
-9,312,000
-18,059,000
4,316,307
-7,255,615
-3,550,735
-9,822,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.